Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Argus Health
Chinese Patent Office
Healthtrust
Johnson and Johnson
Medtronic
McKinsey
Fish and Richardson
Cantor Fitzgerald
Dow
Novartis

Generated: January 19, 2018

DrugPatentWatch Database Preview

HYDROXYUREA Drug Profile

« Back to Dashboard

Which patents cover Hydroxyurea, and what generic alternatives are available?

Hydroxyurea is a drug marketed by Barr, Barr Labs Inc, Par Pharm, and Roxane. and is included in five NDAs.

The generic ingredient in HYDROXYUREA is hydroxyurea. There are ten drug master file entries for this compound. Nine suppliers are listed for this compound. Additional details are available on the hydroxyurea profile page.
Drug patent expirations by year for HYDROXYUREA
Pharmacology for HYDROXYUREA
Ingredient-typeUrea
Drug ClassAntimetabolite
Medical Subject Heading (MeSH) Categories for HYDROXYUREA

US Patents and Regulatory Information for HYDROXYUREA

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Barr HYDROXYUREA hydroxyurea CAPSULE;ORAL 075143-002 Sep 21, 2000 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Barr HYDROXYUREA hydroxyurea TABLET;ORAL 075734-001 Aug 29, 2000 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Barr Labs Inc HYDROXYUREA hydroxyurea CAPSULE;ORAL 075020-001 Jul 30, 1998 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Barr HYDROXYUREA hydroxyurea CAPSULE;ORAL 075143-001 Oct 16, 1998 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Barr Labs Inc HYDROXYUREA hydroxyurea CAPSULE;ORAL 075020-002 Jun 26, 2000 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Roxane HYDROXYUREA hydroxyurea CAPSULE;ORAL 074476-001 Aug 18, 1995 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Par Pharm HYDROXYUREA hydroxyurea CAPSULE;ORAL 075340-001 Feb 24, 1999 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Covington
Cantor Fitzgerald
McKinsey
Daiichi Sankyo
Queensland Health
Fuji
Federal Trade Commission
McKesson
US Department of Justice

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot